Non-small Cell Lung Cancer with Multiple Brain Metastases Treated with Radiosurgery and Erlotinib: A Case Report

Brain metastases are commonly seen complications in non-small cell lung cancer (NSCLC) patients. The incidence of brain metastases is increasing as a result of more effective systemic targeted therapies with prolonged survival. The prognosis is usually poor, and up to six months of median survivals...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahin, Bilgehan, Mustafayev, Teuta, Aydin, Gokhan, Gungor, Gorkem, Yapici, Bulend, Atalar, Banu, Ozyar, Enis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2017
Materias:
Medical Physics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832407/
https://www.ncbi.nlm.nih.gov/pubmed/29507851
http://dx.doi.org/10.7759/cureus.2003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832407/
https://www.ncbi.nlm.nih.gov/pubmed/29507851
http://dx.doi.org/10.7759/cureus.2003

Ejemplares similares